Indo US Bio-TechNSE:INDOUS -0.27%63 Operating Margin % is 11.37% as of Mar. 2026, which is 13% below its 10-year median of 13.03. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹198.40 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 251 Agriculture companies, Indo US Bio-Tech ranks better than 82.47% on this metric.
Indo US Bio-Tech (NSE:INDOUS) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Indo US Bio-Tech Operating Margin % Related Terms
Indo US Bio-Tech Operating Margin % Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOUS vs CTVA, CF: Operating Margin % Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech Operating Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Indo US Bio-Tech's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indo US Bio-Tech (NSE:INDOUS) has a Operating Margin % of 11.37% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Indo US Bio-Tech and its competitors. This is 13% below median its historical median of 13.03. Over the past decade, Indo US Bio-Tech's Operating Margin % has ranged from 4.72 to 17.18. According to the industry distribution chart, Indo US Bio-Tech ranks #44 out of 251 companies in the Agriculture industry, placing it in the top 17.5%.
Is Indo US Bio-Tech's Operating Margin % too high?
Indo US Bio-Tech's current Operating Margin % of 11.37% is 13% below median its 10-year median of 13.03. Over the past 10 years, this metric has ranged from a low of 4.72 to a high of 17.18. The Agriculture industry median Operating Margin % is 6.76. Indo US Bio-Tech's value of 11.37% is 68.2% above this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #44 out of 251 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Operating Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #44 out of 251 companies for Operating Margin %. This places Indo US Bio-Tech in the top 18% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 6.76. Indo US Bio-Tech's value of 11.37% is 68.2% above this benchmark. Historically, Indo US Bio-Tech's own Operating Margin % has ranged from 4.72 to 17.18 over the past decade. While the company's 10-year median is 13.03 vs. the industry median of 6.76, Indo US Bio-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for an Agriculture company?
The median Operating Margin % among Agriculture companies is 6.76, based on 251 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current Operating Margin % of 11.37% is 68.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median Operating Margin % is 6.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current Operating Margin % is 11.37%, which is 13% below median its own 10-year median of 13.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹198.40, compared to a current price of ₹88.75 — trading 55.3% below its estimated fair value. The current Operating Margin % is 11.37%, which is 13% below median its 10-year median of 13.03 and 68.2% above the Agriculture industry median of 6.76. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Operating Margin % is 11.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹88.75 is trading 55.3% below its estimated GF Value™ of ₹198.40.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
Operating Margin %: 11.37% (13% below median its 10-year median of 13.03)
GF Value™: ₹198.40 vs. price of ₹88.75 (55.3% below fair value)
Industry Position: 68.2% above the Agriculture median (#44 of 251)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
